Detalhe da pesquisa
1.
Follicular lymphoma treatment patterns between 2000 and 2014: a SEER-Medicare analysis of elderly patients.
Future Oncol
; 16(8): 353-365, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043384
2.
Does recall period matter? Comparing PROMIS® physical function with no recall, 24-hr recall, and 7-day recall.
Qual Life Res
; 29(3): 745-753, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31701432
3.
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers.
Br J Cancer
; 118(11): 1425-1433, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765150
4.
Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Qual Life Res
; 27(12): 3229-3241, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30187393
5.
Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line.
Nucleic Acids Res
; 44(17): e137, 2016 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27353327
6.
The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology.
Oncologist
; 20(7): 831-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26084809
7.
Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.
J Virol
; 88(13): 7493-516, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24741098
8.
Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital.
J Oncol Pharm Pract
; 20(6): 409-16, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24243920
9.
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion Cancers.
Cancers (Basel)
; 14(7)2022 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406565
10.
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Cancer Treat Res Commun
; 33: 100623, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041373
11.
Transforming approaches to treating TRK fusion cancer: historical comparison of larotrectinib and histology-specific therapies.
Curr Med Res Opin
; 37(1): 59-70, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148054
12.
TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting.
Target Oncol
; 16(3): 389-399, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893941
13.
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib.
Curr Probl Cancer
; 45(6): 100734, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33865615
14.
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors.
Ther Adv Med Oncol
; 12: 1758835920975613, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33425024
15.
Survival benefit associated with treating follicular lymphoma in patients 80 years or older.
J Geriatr Oncol
; 11(1): 55-61, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31706831
16.
Patient-level Factors Associated With the Initial Management of Older Adults Diagnosed With Follicular Lymphoma: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
Clin Lymphoma Myeloma Leuk
; 20(4): e184-e194, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31956071
17.
Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data.
Leuk Lymphoma
; 61(1): 75-83, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31389296
18.
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis.
Cancers (Basel)
; 12(11)2020 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158040
19.
Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).
Oncologist
; 14(3): 291-302, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19276294
20.
Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
J Patient Rep Outcomes
; 3(1): 34, 2019 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209661